Iodine Status and Characteristics of Papillary Thyroid Cancer
ConditionPapillary Thyroid Carcinoma
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorShandong Provincial Hospital
About this trial
The effect of iodine on papillary thyroid cancer has been controversial for many years. The investigators designed a cross-sectional study and aimed to explore the relationship between the serum and urine iodine levels and the clinical and molecular characteristics of papillary thyroid cancer.
Eligibility criteria
Qualifiers
Age range: 18~65 years old, gender not limited;
Living in the residential area for at least 5 years;
Patients diagnosed clinically with thyroid cancer and scheduled for thyroid surgery, with pathological diagnosis of papillary thyroid cancer;
Complete clinical data: including general information, relevant laboratory tests, pathological reports, surgical reports, ultrasound reports, etc.
Disqualifiers
Pathological diagnosis of other types of thyroid cancer;
Diagnosed with other types of cancer;
There are serious comorbidities of the heart, liver, and kidneys;
Trial design
Treatments tested in this trial
- Iodine excess
- Iodine suitable
Treatment groups
600 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov